Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ANAPLASMOSIS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 55 records · Page 3Linked to original sources

Immunization against anaplasmosis and babesiosis. Part III. Evaluation of immunization under field conditions in the Cauca River Valley.

Bovine anaplasmosis and babesiosis constitute serious constraints to efficient cattle production in Colombia. Nine commercial ranches located in the Cauca River Valley were used to evaluate the applicability, safety and economics of the newly developed immunization technology to control these diseases under actual field conditions using the minimum infective doses techniques. A total of 432 calves, 6--8 months old, of different breeds were used in this experiment. Calves born and raised in nonendemic areas of Valle, vaccinated against anaplasmosis and babesiosis and then moved to the endemic zone had developed a high degree of resistance. None of them died or required treatment after field challenge. In comparison, non-vaccinated controls suffered severe clinical anaplasmosis and babesiosis. Eighteen percent dies and 85% required chemotherapy to survive. Calves born and raised in the endemic zones of Valle and vaccinated did not suffer clinical disease nor require treatment after field challenge. However, non-vaccinated controls had 2% mortality and 60% of them required treatment to survive under the same field conditions. The weight gains favored vaccinated animals. The results of this study indicate significant reductions in deaths and production losses of cattle and the economic benefits to the livestock producers in controlling tick-borne diseases by vaccination.

Anaplasmosis↗

Low levels of chlortetracycline for anaplasmosis.

Latent infections of anaplasmosis were eliminated from 10 adult cows by feeding 1.1 mg of chlortetracycline/kg of body weight for 120 days in a ration. Elimination of latent infection was confirmed by a negative reaction to the complement-fixation test for anaplasmosis at 180 days after medication ended and the failure to transmit anaplasmosis on subinoculations of blood from medicated to susceptible animals at 28 days and 180 days after treatment.

Anaplasmosis↗

Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.

Long-acting oxytetracycline was administered intramuscularly (20 mg/kg) at 3-day intervals to each of 16 naturally infected Anaplasma marginale carrier beef cows; 8 of the 16 cows were given 3 injections and the other 8 cows were given 4 injections. Four cows seropositive for A marginale served as untreated controls. Rapid card agglutination and complement fixation tests were performed 5 times during the 130-day posttreatment period. All treated cows became negative to both serologic procedures, whereas control cows remained seropositive. Three splenectomized calves that received pooled blood from the treated cows, 120 days following treatment, remained free of anaplasmosis for 60 days following inoculation. One splenectomized calf that received blood from the control cows developed anaplasmosis. It was concluded that long-acting oxytetracycline can be used to eliminate the naturally acquired carrier state of anaplasmosis in cattle.

Anaplasmosis↗

Efficacy of a new oxytetracycline formulation against clinical anaplasmosis.

A study was conducted to determine whether 1 intramuscular injection of an experimental long-acting oxytetracycline formulation was effective in treatment of induced acute anaplasmosis in cattle and to compare this with the drug response resulting from repeated treatments with an existing, approved oxytetracycline product. The new formulation was supplied in solutions of 200 mg of oxytetracycline/ml and was administered 1 time at the rate of 20 mg/kg of body weight. The experimental formulation was compared with a product providing 50 mg of oxytetracycline/ml which was administered on 2 consecutive days at the dose rate of 10 mg/kg for each treatment. The response to treatment observed in the study animals indicates that 1 injection of the experimental formulation was equivalent to 2 daily injections of the 50 mg/ml product in treating animals with acute bovine anaplasmosis compared with infected nonmedicated control animals. The need for new chemotherapeutic compounds such as this formulation for use in the treatment and control of anaplasmosis is discussed.

Anaplasmosis↗

Mechanical transmission of anaplasmosis by tabanids (Diptera: Tabanidae).

The role of tabanids in the mechanical transmission of anaplasmosis was further clarified by determining the number of horse fly bites needed to transmit the disease and the length of time that horse flies remain mechanically infective. Transmission of anaplasmosis from acutely infected calves to susceptible splenectomized calves was accomplished with as few as 10 horse fly bites. These flies were shown to remain mechanically infective for at least 2 hours after they had obtained a partial blood meal from an acutely infected calf. These data emphasize the efficiency of horse flies in the mechanical transmission of anaplasmosis and indicate that relatively short-distance barriers may not be adequate to prevent transmission between infected and noninfected herds.

Anaplasmosis↗

Comparisons of serotests with calf inoculations for detection of carriers in anaplasmosis- vaccinated cattle.

Fifteen months after discontinuing vaccination for anaplasmosis in a herd of 131 cattle, 126 of the animals were reactive to the complement-fixation or card-agglutination tests. Inoculation of splenectomized calves proved that 9 animals were carriers and 117 animals were free of anaplasmosis. Anaplasmosis vaccination induced titers detectable by the standard serotests that persisted for at least 15 months.

Agglutination Tests↗

Comparison of three methods of immunization against bovine anaplasmosis: evaluation of protection afforded against field challenge exposure.

The efficacy of three immunization methods for bovine anaplasmosis was tested on 88 yearling Normandy cattle which were challenge-exposed under field conditions in an enzootic zone in Colombia, South American. A total of 30 cattle were immunized (premunized) with a presumed mild Colombian isolate of Anaplasma marginale; 29 calves were vaccinated with an attenuated A marginale of ovine origin; and 29 were exposed to a virulent A marginale stabilate of Colombian origin. Twenty-nine nonvaccinated cattle served as controls. Parasitemia, packed cell volume, body weight, and complement-fixation antibody response were monitored to determine host response to challenge exposure. The calves experienced a Babesia challenge exposure following arrival in the enzootic zone, after which a transient increase in Anaplasma parasitemia, accompanied by a decrease in packed cell volume, occurred in most of the vaccinated calves. However, neither clinical anaplasmosis nor mortality due to the disease occurred in the immunized cattle. Twenty-seven of the nonvaccinated calves had signs of clinical anaplasmosis and five (17%) died of the disease.

Anaplasmosis↗

[High serological prevalence of bovine anaplasmosis in North-Cameroon].

Between 1989 and 1994, cases of acute bovine anaplasmosis were rarely diagnosed in Northern Cameroon. However, the Becton-Dickinson anaplasmosis card test revealed high prevalence rates, especially in the North and Far North provinces. Bovine anaplasmosis might be clinically important in areas where the proportion of non-immune cattle is higher.

Anaplasmosis↗

The cost of anaplasmosis in the Red River Plains and south-east areas of Louisiana.

Losses from morbidity and mortality due to anaplasmosis were assessed in beef and dairy cattle of the Red River Plains and south-east areas of Louisiana. The cost of treatment and prevention of anaplasmosis and losses in milk production and those due to deaths or culling were valued at $0.5 million for the year 1983 in these two areas. The cost of prevention included the use of tetracyclines in feed and salt-mineral supplements, injectable tetracycline, vaccination and an estimated 10% of the cost of insecticidal ear tags, sprays, pour-on applications and dust bags. The remainder of these costs and the total cost of vector control in dairy cattle was attributed to the control of fly annoyance. Treatment costs included veterinary fees and the owner's treatment costs, including labour costs.

Anaplasmosis↗

Incidence of clinical anaplasmosis in cattle in the Red River Plains and south-east areas of Louisiana.

Incidence rates for clinical anaplasmosis were estimated for dairy and beef cattle in the Red River Plains and South-east areas of Louisiana. Annual incidence rates of 0.33% and 0.21% were found in dairy cows for 1983 and 1984 while a 31.0% rate was found in beef cows for 1983. The rates were based on postal surveys of dairy and beef cattle producers. A survey of veterinary practices and a follow-up of respondents to the surveys provided a description of 256 cases of anaplasmosis. Eighty-one percent of the clinical cases occurred in cattle aged 4-6 years and 88% of the cases occurred during the months of July-September.

Anaplasmosis↗

Efficacy of purified Anaplasma marginale initial bodies as a vaccine against anaplasmosis.

Anaplasma marginale initial bodies of the Florida strain were purified from infected erythrocytes using a combination of ultrasonic disruption, nonionic detergent and differential centrifugation. Immunochemical analysis revealed at least 12 A. marginale proteins in the molecular mass (m) range 81-15 kDa with a prominent band at 38 kDa. Several of these proteins remained insoluble in the presence of nonionic detergent. Preparations of purified Anaplasma initial bodies contained negligible erythrocytic contamination, as confirmed by the minimal induction of isoantibodies against bovine blood group antigens and the absence of delayed-type hypersensitivity to erythrocytic antigens in immunized animals. A total of 33 crossbred and purebred Holstein cattle were vaccinated with either 1.5, 1.0, or 0.1 mg protein of intact initial bodies, or with 1.0 mg of solubilized Anaplasma protein. The immunogens were supplemented with 3.0 mg Quil-A saponin adjuvant and administered in 2 subcutaneous injections given at a 4-week interval. A similar number of nonvaccinated cattle served as controls. Three months after vaccination, all cattle were challenged by inoculation of 10(9) virulent A. marginale of either the homologous (Florida) or heterologous (Venezuelan) strains. Vaccinated cattle showed solid protection after homologous and heterologous challenge, characterized by parasite clearance and minimal hematocrit reductions. Initial data from four field vaccine trials revealed a reduced incidence of clinical anaplasmosis among immunized animals. Use of immunogens consisting of purified A. marginale initial bodies offers a potential immunoprophylactic approach to control of bovine anaplasmosis.

Anaplasma↗

Seroepidemiology of bovine anaplasmosis and babesiosis in Venezuela.

The serological prevalence of bovine anaplasmosis and babesiosis in the Centro-Occidental region of Venezuela was determined using the indirect fluorescent antibody (IFA) and latex agglutination (LAT) tests. Anaplasma marginale IFA and LAT prevalence rates were 57.7 and 48.6% respectively for cattle of all ages and breeds. The respective prevalence of IFA activity to B. bigemina and B. bovis was 78.2 and 38.8%. The LAT test specific only for Babesia spp. revealed that 61.4% of the animals tested were serologically positive for Babesia parasites. Anaplasma marginale and B. bigemina organisms were detected in peripheral blood smears of 21.1 and 7.5% respectively of cattle surveyed. A longitudinal survey of antibody activity and incidence of parasitaemia for Anaplasma and Babesia infections was conducted in two groups of calves from their birth to seven months of age. The animals generally experienced infections between three and four months of age the period subsequent to decline in colostral antibody levels. Seroepidemiological data are considered in the formulation of proposed vaccination regimens for anaplasmosis and babesiosis.

Anaplasmosis↗

A new hemolytic assay for bovine serum complement and its application during experimental bovine anaplasmosis.

A new hemolytic assay for bovine complement is presented. Using this assay we found a significant reduction in bovine serum complement activity during the acute phase of anaplasmosis, and an increase in the sensitivity of the red blood cells (RBC) to bovine complement lysis in vitro. The new hemolytic test is performed with bovine RBC, rabbit anti-bovine RBC serum and bovine serum complement. An isotonic sucrose Tris-buffered saline solution of ionic strength 0.094 and pH 7.2 was found to be adequate for this test. The titres obtained with this new assay, which uses autologous RBC, are comparable with those obtained using the guinea pig RBC assay. The finding of a reduction in bovine serum complement during anaplasmosis may be suggestive of a mechanism responsible for the pathology of this disease.

Anaplasmosis↗

Observations on histamine, serotonin, cortisol and cortisol binding globulins in bovine anaplasmosis.

Changes in histamine, serotonin, cortisol and cortisol binding globulin (CBG) levels were observed in Anaplasma marginale-infected bovine calves. In addition, packed cell volume (PCV), platelet number and percentage parasitaemia were also recorded. The whole blood histamine and serotonin values rose significantly (P less than 0.01 and P less than 0.025, respectively) during the acute stage of Anaplasma infection. Higher serum cortisol and CBG levels (P less than 0.05) were observed in acute and carrier infections, respectively. A sharp drop in thrombocyte count (59%) and PCV (33%) was also noticed in clinical anaplasmosis. The results suggest that the higher levels of biogenic amines which are known to produce increased vasodilation, capillary permeability and tissue anoxia and hypercortisolaemia to protect animals from stress and cell damage may play a similar role in the pathogenesis of acute anaplasmosis.

Anaplasmosis↗

Epidemiology of babesiosis and anaplasmosis in South and Central America.

Babesiosis (Babesia bovis and Babesia bigemina) and anaplasmosis (Anaplasma marginale) affect native cattle from Uruguay and northern Argentina to Guatemala. The distribution of Babesia follows the dissemination of the tick vector. Seroepidemiological studies showed that enzootic instability exist in herds in several areas of the region. However, clinical cases occurred less frequently than expected. The babesial tick infection rate is related to the vector abundance which in turn is regulated by climate. Bos indicus cattle, because of tick resistance, are less likely to be infected by the vector. This can result in herd instability, but clinically is partly compensated by the resistance of Bos indicus and their crosses to babesiosis. Excessive use of acaricides and rotational grazing appears to be related to outbreaks of babesiosis especially in dairy cattle. Factors involved in the epidemiology and transmission of anaplasmosis are not well defined. The role of ticks, haematophagous diptera, iatrogenic and intrauterine transmissions needs to be investigated under local conditions. Therefore, the knowledge of this disease is meager. Utilization of biotechnological methods may help in obtaining information on Babesia-Boophilus-Bos relationship and on the transmission of A. marginale.

Anaplasmosis↗

[Anaplasmosis in a Swiss dairy farm: an epidemiological outbreak investigation].

In summer of 2002, a case of severe clinical bovine anaplasmosis caused great losses in a dairy farm of an animal trader in Grisons. This article outlines the general approach of an outbreak investigation considering the case of anaplasmosis as an example. The goals of such investigations are to identify and eliminate the source of a disease outbreak in order to avoid additional cases. In addition, recommendations should be developed for preventing or limiting the magnitude of similar outbreaks in the future. In the outbreak presented, the causative agents were probably brought into the dairy farm by animal trade. Due to the large herd size, a missing quarantine for new animals and the coinfection with several pathogens, this case led to a high number of fatalities. The investigations of this outbreak demonstrated the importance of an universal and consistent identification of individual animals for the reconstruction of their movements. The veterinary practitioner should be reminded to act cautiously when facing strange clinical cases and to also consider "exotic diseases" as a possible cause.

Anaplasmosis↗

Different seasonal occurrence of anaplasmosis outbreaks in beef and diary cattle in an area of Argentina free of Boophilus microplus ticks.

The seasonal occurrence of anaplasmosis (Anaplasma marginale) outbreaks in dairy and beef cattle was analysed for a region of Argentina (29 degrees to 31 degrees S and 58 degrees to 62 degrees W) that is free of Boophilus microplus ticks, using data collected from December 1978 to November 1995. The outbreaks were confirmed by inspection of blood smears obtained from sick or dead cattle. A total of 94 outbreaks were confirmed by inspection of blood smears obtained from sick or dead cattle. A total of 94 outbreaks were identified: 48 in beef cattle and 46 in dairy herds. The proportional seasonal distribution of outbreaks was different in beef and dairy cattle (chi-square = 15.08, P < 0.01). While no seasonal pattern of anaplasmosis outbreaks was found in dairy cattle, there was a concentration of outbreaks during the summer months (54% of the total) in beef cattle. Rural practices that are carried out more frequently on dairy than on beef cattle may have favoured iatrogenic transmission of A. marginale in the milk production system.

Anaplasmosis↗

Human anaplasmosis presenting as atypical pneumonitis in France.

Human anaplasmosis is a febrile illness caused by Anaplasma phagocytophilum, an intracellular bacterium transmitted by Ixodes ticks in the United States and Europe. Although cough is reported in 30% of the American cases, interstitial pneumonitis has been noted only once. Of the 9 confirmed cases reported in Europe, 3 presented with atypical pneumonitis. A. phagocytophilum should be added to the list of agents responsible for interstitial pneumonitis, especially in areas where human anaplasmosis is endemic.

Anaplasma phagocytophilum↗